Overview of recent advances in metastatic triple negative breast cancer

doi:10.5306/wjco.v12.i3.164

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 3

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (13123)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Tables (1-6) series.

Item

Count

PDF

980

WORD

216

HTML

8592

Tables (1-6)

406

Sum=10194

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

379

Download

817

Sum=1196

Publishing Process of This Article

Item

Count

Browse

501

Download

1232

Sum=1733

Mar 24, 2021 (publication date) through Dec 21, 2024

Times Cited of This Article

Times Cited (55)

Journal Information of This Article

Publication Name

World Journal of Clinical Oncology

ISSN

2218-4333

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Clin Oncol. Mar 24, 2021; 12(3): 164-182
Published online Mar 24, 2021. doi: 10.5306/wjco.v12.i3.164

Table 1 Historical outcomes in metastatic triple negative breast cancer

	ORR (%)	PFS (mo)	OS (mo)
Single agent chemotherapy
1L	10.0-28.0	3.5-5.4	9.9-17.5
2L	6.0-18.0	2.7-3.4	9.2-15.2
Combination chemotherapy
1L	14.8-64.3	4.8-9.0	13.9-24.2
2L+	27.0¹-60.0	2.9-7.0	8.1-16.5

¹1-3Lines. Adapted from: Li et al[89]. ORR: Overall response rate; PFS: Progression free survival; OS: Overall survival.

Citation: O'Reilly D, Sendi MA, Kelly CM. Overview of recent advances in metastatic triple negative breast cancer. World J Clin Oncol 2021; 12(3): 164-182
URL: https://www.wjgnet.com/2218-4333/full/v12/i3/164.htm
DOI: https://dx.doi.org/10.5306/wjco.v12.i3.164